Stated position
Empower Medicare to negotiate lower prescription drug prices and cap out-of-pocket costs for Medicare Part D enrollees, as author and lead sponsor of the Lower Drug Costs Now Act (H.R. 3), which would require federal negotiation of at least 25 brand-name drug prices (including insulin) each year.
Stated position. What this official has said they believe on this issue — a sourced claim, shown distinctly from any assessment of what they did. It is never scored and never affects the Integrity Score.
Derived from a tracked promise: “Empower Medicare to negotiate lower prescription drug prices and cap out-of-pocket costs for Medicare Part D enrollees, as author and lead s…”
Sources
“To establish a fair price negotiation program, protect the Medicare program from excessive price increases, and establish an out-of-pocket maximum for Medicare part D enrollees.”
- U.S. Congress (Congress.gov)https://www.congress.gov/bill/117th-congress/house-bill/3 ↗
“Lower Drug Costs Now Act; sponsor Rep. Frank Pallone (D-NJ-6).”